Westchester Capital Management (New York)’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150,000
Closed -$1.52M 468
2022
Q3
$1.52M Hold
150,000
0.04% 306
2022
Q2
$1.51M Hold
150,000
0.04% 262
2022
Q1
$1.51M Hold
150,000
0.04% 258
2021
Q4
$1.51M Buy
+150,000
New +$1.52M 0.04% 227

Other funds holding PBAXU

Westchester Capital Management (New York)'s PBAXU Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 150,000 shares — an estimated $1.52M sold.

Westchester Capital Management (New York) first reported a position in PBAXU in Q4 2021 and held it in 4 quarters. The position peaked at $1.52M in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

  • Westchester Capital Management (New York) reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 150,000 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $1.52M.
  • Westchester Capital Management (New York) first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Westchester Capital Management (New York)'s Phoenix Biotech Acquisition Corp. Unit position peaked at $1.52M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.